Cover Image
Market Research Report
Product code 
1047087

Asia-pacific Clinical Trial Management Market Forecast 2022-2030

Published: | Inkwood Research | 169 Pages | Delivery time: 2-3 business days

Price

Back to Top
Asia-pacific Clinical Trial Management Market Forecast 2022-2030
Published: January 19, 2022
Inkwood Research
Content info: 169 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

KEY FINDINGS

The Asia-Pacific clinical trial management market is estimated to record a CAGR of 13.55% during the forecast period, 2022-2030. The rising number of hospitals equipped with advanced medical facilities, enhanced healthcare infrastructure, and technological advancements in healthcare drive market growth.

MARKET INSIGHTS

South Korea, Japan, China, Indonesia, Thailand, Australia & New Zealand, India, Vietnam, and Rest of Asia-Pacific, are evaluated for the growth analysis of the Asia-Pacific clinical trial management market. In Japan, R&D is highly prioritized in the pharmaceutical industry, attributed to the country's medicine market and the strength of local research institutions. It ranks third globally with regard to biomedical R&D expenditure. The deregulation of the pharma industry has facilitated a swifter and more efficient drug approval process, encouraging foreign investment. The minimized time required to evaluate new drugs has resulted in international pharma manufacturers re-establishing R&D centers and raising their investments in the country. The country has a good clinical trial infrastructure, healthcare capabilities, high-quality standards, and a competent medical workforce. Such factors drive market growth in Japan.

In Indonesia, the surging population growth has increased the demand for safe and effective healthcare services. The country's shifting epidemiology of chronic illness projects an increase in unmet healthcare demands. Further, Thailand is known globally for its high-quality and affordable care. The country's medical tourism industry ranks sixth as per the International Healthcare Research Center, on the basis of medical tourism costs and destination attraction. Moreover, private hospitals incorporate the latest medical facilities. Such factors are expected to fuel market growth in these countries.

COMPETITIVE INSIGHTS

Some eminent companies in the market include: IBM Corporation, Mednet Solutions Inc, Oracle Corporation, Parexel International Corporation, Advarra (Forte Research Systems Inc), etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Product Code: 24389

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. PARENT MARKET ANALYSIS - HEALTHCARE
  • 3.2. MARKET SCOPE
  • 3.3. KEY DRIVERS
    • 3.3.1. OUTSOURCING OF CLINICAL TRIALS
    • 3.3.2. GROWING NUMBER OF CLINICAL TRIALS
    • 3.3.3. AWARENESS REGARDING THE BENEFITS OF USING CTM SOFTWARE
    • 3.3.4. INCIDENCES OF CHRONIC DISEASES
    • 3.3.5. RESEARCH & DEVELOPMENT
  • 3.4. KEY RESTRAINTS
    • 3.4.1. SCARCITY OF SKILLED HEALTHCARE PROFESSIONALS
    • 3.4.2. COST OF IMPLEMENTATION
    • 3.4.3. SECURITY CONCERNS

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON CLINICAL TRIAL MANAGEMENT MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE

5. MARKET BY END-USER

  • 5.1. PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
  • 5.2. CLINICAL RESEARCH ORGANIZATIONS
  • 5.3. HEALTHCARE PROVIDERS

6. MARKET BY PRODUCT TYPE

  • 6.1. ENTERPRISE-BASED CTM
  • 6.2. SITE-BASED CTM

7. MARKET BY DEPLOYMENT MODEL

  • 7.1. WEB-BASED DEPLOYMENT
  • 7.2. ON-PREMISE DEPLOYMENT
  • 7.3. CLOUD-BASED DEPLOYMENT

8. MARKET BY COMPONENT

  • 8.1. SOFTWARE
  • 8.2. HARDWARE
  • 8.3. SERVICES

9. GEOGRAPHICAL ANALYSIS

  • 9.1. ASIA-PACIFIC
    • 9.1.1. MARKET SIZE & ESTIMATES
    • 9.1.2. KEY GROWTH ENABLERS
    • 9.1.3. KEY CHALLENGES
    • 9.1.4. KEY PLAYERS
    • 9.1.5. COUNTRY ANALYSIS
      • 9.1.5.1. CHINA
      • 9.1.5.2. JAPAN
      • 9.1.5.3. INDIA
      • 9.1.5.4. SOUTH KOREA
      • 9.1.5.5. INDONESIA
      • 9.1.5.6. THAILAND
      • 9.1.5.7. VIETNAM
      • 9.1.5.8. AUSTRALIA & NEW ZEALAND
      • 9.1.5.9. REST OF ASIA-PACIFIC

10. COMPETITIVE LANDSCAPE

  • 10.1. KEY STRATEGIC DEVELOPMENTS
    • 10.1.1. MERGERS & ACQUISITIONS
    • 10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 10.1.3. PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
  • 10.2. COMPANY PROFILES
    • 10.2.1. ADVARRA (FORTE RESEARCH SYSTEMS INC)
    • 10.2.2. ARISGLOBAL LLC
    • 10.2.3. BIOCLINICA INC
    • 10.2.4. BIO-OPTRONICS INC
    • 10.2.5. IBM CORPORATION
    • 10.2.6. MEDIDATA SOLUTIONS INC
    • 10.2.7. MEDNET SOLUTIONS INC
    • 10.2.8. ORACLE CORPORATION
    • 10.2.9. PAREXEL INTERNATIONAL CORPORATION
    • 10.2.10. VEEVA SYSTEMS INC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - CLINICAL TRIAL MANAGEMENT
  • TABLE 2: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 3: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 4: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 5: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 6: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODEL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 7: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODEL, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 8: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 9: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 10: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 11: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 12: KEY PLAYERS OPERATING IN ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET
  • TABLE 13: LIST OF MERGERS & ACQUISITIONS
  • TABLE 14: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 15: LIST OF PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021
  • FIGURE 6: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, 2022-2030 (IN $ MILLION)
  • FIGURE 7: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY CLINICAL RESEARCH ORGANIZATIONS, 2022-2030 (IN $ MILLION)
  • FIGURE 8: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY HEALTHCARE PROVIDERS, 2022-2030 (IN $ MILLION)
  • FIGURE 9: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2021
  • FIGURE 10: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY ENTERPRISE-BASED CTM, 2022-2030 (IN $ MILLION)
  • FIGURE 11: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY SITE-BASED CTM, 2022-2030 (IN $ MILLION)
  • FIGURE 12: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY DEPLOYMENT MODEL, IN 2021
  • FIGURE 13: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY WEB-BASED DEPLOYMENT, 2022-2030 (IN $ MILLION)
  • FIGURE 14: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY ON-PREMISE DEPLOYMENT, 2022-2030 (IN $ MILLION)
  • FIGURE 15: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY CLOUD-BASED DEPLOYMENT, 2022-2030 (IN $ MILLION)
  • FIGURE 16: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY COMPONENT, IN 2021
  • FIGURE 17: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY SOFTWARE, 2022-2030 (IN $ MILLION)
  • FIGURE 18: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY HARDWARE, 2022-2030 (IN $ MILLION)
  • FIGURE 19: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, BY SERVICES, 2022-2030 (IN $ MILLION)
  • FIGURE 20: ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 21: CHINA CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 22: JAPAN CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 23: INDIA CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 24: SOUTH KOREA CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 25: INDONESIA CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 26: THAILAND CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 27: VIETNAM CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 28: AUSTRALIA & NEW ZEALAND CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 29: REST OF ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)